INTRODUCTION
============

Postoperative surgical site infection (SSI) is one of the most serious and costly challenges of modern cardiac surgery.^[@bib1]^ The incidence of this complication, depending on the facility, ranges from 0.5% to 20%^[@bib2],[@bib3]^ and is associated with a significant increase in medical costs.^[@bib4]^ Epidemiologic studies conducted in the US in 2009 showed that, in patients with SSI, hospital stay was extended by an average of 9 days, increasing the cost of hospitalization by more than \$20,000 for each patient, or nearly \$1 billion a year. Similarly, at the authors' facility in Poland, in about 9% of patients with SSI, hospital stay was extended by an average of 5 days, increasing the cost of treatment by an average of 8,000 zł.^[@bib5]--[@bib7]^

Infections in sternotomy wounds are divided into superficial wound infections (SWIs), if the infection is limited to the skin and subcutaneous tissue, and deep wound infections (DWIs) when the inflammatory process includes the sternum and mediastinum.

Type 2 diabetes is, along with chronic obstructive pulmonary disease, the most common comorbidity of patients undergoing cardiac surgery. Its occurrence in patients undergoing cardiac surgery is estimated at 20% to 30%, of which almost three-quarters of cases are intensively treated with insulin.^[@bib8]--[@bib10]^ Despite such treatment, because of frequent dietary errors or insufficient glycemic control and insulin supplementation, a significant percentage of patients (about 5%-10%) report for cardiac surgery with uncontrolled diabetes, in which their glycated hemoglobin levels exceed 8%. These patients, despite increased IV insulin therapy, remain at high risk of wound healing complications because of impaired collagen production. Further, chronic hyperglycemia reduces tissue resistance to infection, impairs peripheral blood supply to tissues, and induces neuropathy.

Treatment of SWI is a clinical challenge. It consists of intense IV antibiotic therapy, surgical debridement, and the use of vacuum wound closure methods.^[@bib2]^ A more recent treatment option is self-adhesive wound dressings containing nanocrystalline silver. They offer the bactericidal properties of silver enclosed in thin nanomesh fibers.^[@bib11]^ Clinical studies have confirmed their high effectiveness in the treatment of diabetic foot ulcers and wounds infected with multidrug-resistant bacteria.^[@bib12]--[@bib14]^ The high efficacy of this dressing has also been demonstrated in the treatment of burns.^[@bib15]^

The present study attempts to assess the efficacy of nanocrystalline silver-coated dressings in preventing SWI in patients with diabetes who have undergone cardiac sternotomy.
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METHODS
=======

The study was designed as a pilot, single-center, prospective, open-label clinical trial. The research was carried out in the General Analytics Laboratory of the authors' hospital. It involved 194 patients who met the inclusion criteria and signed consent forms (Table [1](#T1){ref-type="table"}).
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Patients were randomized into two homogeneous groups. In all patients, blood draws were required to assess glycated hemoglobin, fructosamine, and creatinine levels. The dressings were administered in the OR after the cardiac surgery. The control group (n = 97) received a standard sterile dressing (Elastopor STERIL; ZARYS International Group, Zabrze, Poland). The study group (n = 97) received 10 × 10-cm silver dressings (Acticoat Flex 3 fitted with the Opsite Post Op Visible; Smith & Nephew, Fort Worth, Texas). After 3 days, a 10 × 25-cm silver dressing (Acticoat Surgical; Smith & Nephew) was applied.

In the control group, the frequency of dressing changes was consistent with the facility's normal treatment schedule (maintained up to 2 days after surgery and then changed daily). In the intervention group, the frequency of dressing changes was in accordance with the manufacturer\'s instructions (maintained up to 3 days after surgery and then changed every 3 days). Wounds were evaluated each time the dressing was changed. If no adverse outcomes were noted, the patient was discharged after 5 to 7 days for further treatment in outpatient settings. On postoperative day 14, the patient was invited to the authors' outpatient clinic to remove their stitches. On postoperative day 30, the patients were assessed based on a detailed telephone interview or a visit to the infirmary.

The appearance of any SWI within 30 days was treated as the primary endpoint. For SWI diagnosis, the patient had to meet the following criteria: (1) a red, swollen, and painful wound; (2) positive bacterial culture from the tissue or fluid removed from the wound; and (3) depth does not pass below the fascia of the pectoral muscle, and sternum bone fragments do not show pathological mobility. For DWI diagnosis, the patient had to meet at least one of the following criteria: (1) positive bacterial culture from the tissue or fluid removed from the wound; (2) evidence of infection of the wound during surgery such as purulent or serous leakage from the wound or mediastinum; (3) any of the following: chest pain, instability of the sternum, fever (\>38° C), or positive culture from blood or a mediastinal drainage. When infection occurred, patients were to be treated according to established protocols.

Statistical Analysis
--------------------

Statistical analysis was performed using the Microsoft Office Excel 2010 and Statistica 12.0 computer programs. To compare the values expressed in percentages, a significance test of the difference between two structure indices was used, including the *χ*^2^ test and the Mann-Whitney *U* test. *P* \< .05 was considered statistically significant.

RESULTS
=======

The intervention and control groups were homogeneous in terms of baseline parameters (Table [2](#T2){ref-type="table"}), differing only in glomerular filtration rate. The occurrence of the primary endpoint in both groups is described in Table [3](#T3){ref-type="table"}. No DWI criteria were met in either the study or control group. However, SWI occurred in 26 patients (13.4%): 11 patients in the intervention group and 15 in the control group. This difference was not statistically significant (11.7% vs 16.67%, *P* = .450).
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ENDPOINTS BY GROUP
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Patients were divided by occurrence of SWI in search for determinants of wound infections (Table [4](#T4){ref-type="table"}). However, none of the analyzed parameters appeared to be a significant factor of SWI.
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COMPARISON OF PATIENTS WITH SURGICAL WOUND INFECTION BUT WITHOUT INFLAMMATION

![](swc-32-521-g004)

DISCUSSION
==========

Postoperative wound infections are one of the most serious complications of cardiosurgical procedures. In this study, 13.4% of patients (26 of 194) with type 2 diabetes had SWI after coronary artery bypass grafting, which is similar to a previously reported study.^[@bib16]^ Risk factors related to the patient include comorbidities (mainly diabetes and chronic obstructive pulmonary disease), and factors related to the procedure include time-consuming open-heart surgery with prolonged extracorporeal circulation, multiple blood transfusions or preparations, and reoperations because of bleeding or tamponade.^[@bib6]^ However, type 2 diabetes is the most common predisposing factor for SWI.^[@bib16]^ Issues attributable to chronic hyperglycemia are compounded by impaired blood supply to the sternum and adjacent tissues.

Treatment of SWI is still a clinical challenge. In addition to IV antibiotic therapy, surgical debridement, and the use of flow drainage, providers can use negative-pressure wound therapy (NPWT) to clean the wound and increase its blood supply. The effectiveness of NPWT has been repeatedly confirmed in numerous clinical trials,^[@bib17]^ and is now standard in the treatment of serious wounds after cardiac surgery. However, NPWT is associated with a need to hospitalize a patient and replace the suction system, on average, every 3 to 4 days.^[@bib17]^

Nanocrystalline silver dressings have proven superiority to standard dressings in treating diabetic foot ulcerations.^[@bib18]^ They use the bactericidal properties of silver to create an antibacterial barrier that functions for up to 72 hours. Dressings of this type are effective against the pathogens most commonly found in SWI: *Pseudomonas aeruginosa*, *Staphylococcus aureus*, and so on. However, this study showed that nanocrystalline-coated silver dressings have similar results to standard wound care in the prevention of sternal wound infections in patients with diabetes after coronary artery bypass grafting.

Limitations and Recommendations for Future Research
---------------------------------------------------

This study has several important limitations that warrant caution in clinical extrapolation of these results. Despite the advantages of a prospective randomized study, the sample size was relatively small, and larger-scale studies may be needed to support these findings. Further, on postoperative day 30, most patients were assessed based on a detailed telephone interview rather than during a visit to the hospital. If the patients who were contacted via telephone had been asked to send a picture of the wound or required to come in person, this could have potentially increased the detectability of the primary endpoint.

CONCLUSIONS
===========

This study found that the frequency of sternotomy wound infection in patients with type 2 diabetes after surgical coronary revascularization is similar in patients treated with standard wound dressings versus nanocrystalline silver dressings. Because the silver dressings require replacement every day, standard wound care offers an inexpensive alternative that providers should consider.
